Antidiabetic effects and gene expression profiling in obese mice treated with Isaria sinclairii over a 6-month period.

Abstract

The molecular mechanisms underlying the glucose-lowering effects of Isaria sinclairii (Cicada Dongchunghacho), a fungus cultured on silkworm, are not fully elucidated. Thus the glucose-lowering effects of I. sinclairii as potential an antidiabetic agent were investigated in C57BL/6 obese (ob/ob) mice over a 6-mo period. For a period of 26 wk, ob mice were administered either 5 or 10% (w/w) I. sinclairii powder (IS), 10% dry mulberry leaf powder (ML), or 10% silkworm (SW) powder in the standard diet while a control group received only standard diet. The ML and SW preparations served as positive controls. Isaria sinclairii at 10% in the diet was more effective in reducing body weight compared to 10% ML, 10% SW, or 5% I. sinclairii. The fall in blood glucose levels in the groups treated for 26 wk was greater in both IS groups at 1 mo compared to ML or SW but equal in all groups at 6 mo. Microarray analyses were performed with a mouse 7.4K cDNA clone set array to identify the gene-expression profiles for the IS-, ML-, and SW-exposed ob mouse liver. The 10% IS group, compared to control, showed that 15 genes including glucokinase (Gk-rs1) and LDL receptor relating protein 1 were upregulated and 12 genes including cell translocation gene2 (antiproliferative) and hydroxyprostaglandin dehydrogenase (Hpgd 15) were downregulated. Upregulation of Gk-rs 1 and downregulation of Hpgd 15 were previously shown to occur in drug-induced suppression of diabetes. With ML, Lepr (leptin receptor), Pik3cb (phosphatidylinositol 3-kinase), and Prodh (proline dehydrogenase), related to suppression of diabetes, were upregulated. In the case of SW, the enzymes (G2an, alpha glucosidase 2) and Mmp9 (matrix metalloproteinase 9) involved in elevation of blood glucose levels were both downregulated. Data suggest that I. sinclarii is effective in lowering blood glucose due to the upregulation of glucokinase (Gk-rs1) and downregulation of hydroxyprostaglandin dehydrogenase (Hpgd 15), both associated with suppression of diabetes, indicating that microarray analysis is a useful tool to assess pharmacological potency of therapeutic compounds.

• Authors: Mi Young Ahn, Sang Duck Jee, Byung Mu Lee, Ji-Hye Yeon, Kun-Koo Park, Jae Sam Hwang, Eun Young Yun
• Journal: Journal of toxicology and environmental health. Part A (J Toxicol Environ Health A) Vol. 73 Issue 21-22 Pg. 1511-20 ( 2010) ISSN: 1528-7394 [Print] England
• PMID: 20954077 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Biomarkers
• Blood Glucose
• Hypoglycemic Agents
• Plant Extracts
• Hydroxyprostaglandin Dehydrogenases
• Glucokinase

Topics

• Animals
• Ascomycota (chemistry)
• Biomarkers (metabolism)
• Blood Glucose
• Body Weight (drug effects)
• Diabetes Mellitus, Experimental (drug therapy, metabolism)
• Female
• Gene Expression (drug effects)
• Gene Expression Profiling
• Glucokinase (genetics, metabolism)
• Hydroxyprostaglandin Dehydrogenases (genetics, metabolism)
• Hypoglycemic Agents (pharmacology)
• Insulin Resistance
• Liver (drug effects, metabolism, pathology)
• Mice
• Mice, Inbred C57BL
• Mice, Mutant Strains
• Obesity (blood, drug therapy, genetics)
• Oligonucleotide Array Sequence Analysis
• Plant Extracts (pharmacology)
• Up-Regulation (drug effects)